年龄相关性白内障防治药物的相关研究进展
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金资助项目(No.81470618); 黑龙江省青年科学基金项目(No.QC2013C099)


Research progress of drugs that can control and prevent age-related cataract
Author:
Affiliation:

Fund Project:

National Natural Science Foundation of China(No.81470618); Heilongjiang Province Science Foundation for Youths(No.QC2013C099)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    人眼晶状体是一个由上皮细胞以及其分化而来的纤维细胞共同组成的无血管透明器官。随着年龄的增长,晶状体混浊并可在一定程度上影响视力甚至致盲称为年龄相关性白内障(age-related cataract,ARC),其公认的治疗手段为手术治疗,但一部分初发白内障也可通过药物控制其发生发展。本文就ARC相关防治药物及其重要成分进行介绍,并概括总结了近年来药物在白内障防治过程中的临床应用及研究进展。

    Abstract:

    The lens is a transparent tissue without vessel, which is mainly composed of a layer of epithelium cells and differentiating fiber cells. With aging, lens opacity can deteriorate vision significantly and even result in blindness, which is termed as age-related cataract(ARC). A fully developed treatment method of ARC is surgery, while a few cataracts in the initial stage can be suppressed via drugs efficiently.This paper introduced relevant drugs and important ingredients that can suppress and prevent ARC, and then summarizes clinical applications and existing researches with respect to drug treatments in the process of cataract suppression and treatment.

    参考文献
    相似文献
    引证文献
引用本文

姜玟彤,刘平.年龄相关性白内障防治药物的相关研究进展.国际眼科杂志, 2017,17(2):243-246.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-10-12
  • 最后修改日期:2016-12-27
  • 录用日期:
  • 在线发布日期: 2017-01-20
  • 出版日期: